A National Directory of Drug Treatment Centers and Alcohol Treatment Centers, Therapists and Specialists. A free, simple directory providing assistance and guidance for those seeking help regarding alcohol addiction, drug addiction, dependency and many other conditions that affect the mind, body and soul.
Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Combination Benefits Patients With Comorbid Depression, Alcoholism

Treatment that combines sertraline and naltrexone appears to be superior to treatment with either drug alone, as well as to placebo, for individuals with depression and alcohol dependence.

Patients receiving the combination treatment were more likely to achieve abstinence and had delayed relapse to heavy drinking, according to a report posted in the March 15 AJP in Advance.

“[T]he co-occurrence of depression and alcohol dependence is highly prevalent and difficult to treat successfully,” wrote Helen Pettinati, Ph.D., and colleagues at the University of Pennsylvania Treatment Research Center. “The present findings suggest that patients with both disorders would benefit from combination treatment with an antidepressant and medication for alcohol dependence. More patients receiving the medication combination achieved abstinence from alcohol compared with patients receiving single-medication or placebo treatments. In addition, more patients in the medication-combination group were not depressed at the end of treatment.”

alcohol addiction dependence

Alcohol dependence and depression get the best of you.

The effect of the combination treatment on both drinking and depression is noteworthy, as there has been limited and contradictory evidence in the literature on the efficacy of antidepressants in patients with alcohol dependence.

In this study, 170 men and women, aged 21 to 75, were randomly assigned to one of the following four treatment conditions for 14 weeks:

  • 42 patients received naltrexone (100 mg/day) plus sertraline (200 mg/day)
  • 49 patients received naltrexone (100 mg/day) plus placebo
  • 40 patients received sertraline (200 mg/day) plus placebo
  • 39 patients received double placebo.
  • All patients also received 14 weeks of cognitive-behavioral therapy.

All patients had DSM-IV diagnoses of major depression and alcohol dependence. Inclusion criteria were consumption of an average of at least 12 alcoholic drinks per week, consumption of an alcoholic drink on at least 40 percent of the 90 days before treatment, three days of consecutive abstinence just before starting treatment, and a Hamilton Rating Scale for Depression (HAM-D) score of at least 10 at the time of randomization.

Primary drinking outcomes were total abstinence, defined as the percentage of patients who were abstinent on all days of the 14-week treatment period, and time to relapse. The latter was defined as the median number of days in treatment before a heavy drinking day. (A heavy drinking day was defined as consumption of at least five drinks in one day for men and at least four drinks in one day for women.)

Primary depression outcomes were no depression at the end of treatment—defined as a HAM-D score of 9 or less in the final three weeks of treatment—and HAM-D score in the last treatment week. Results showed that more patients in the sertraline plus naltrexone group (53.7 percent) were abstinent for the 14 weeks of treatment than the patients in the other groups combined.

Although there were no statistical differences among the groups across the 14 weeks with regard to depression, the sertraline plus naltrexone group appeared to have lower HAM-D scores during selected weeks relative to the other groups, and the sertraline group appeared to have higher HAM-D scores during selected weeks relative to the other groups.

“The depression outcome findings in our study were surprising in light of the findings in selected prior literature reporting that depressed alcohol-dependent patients had a more robust reduction in depressive symptoms with an antidepressant than with placebo,” the authors stated. “However, our study found no advantage in treatment with sertraline alone in depressive symptom reduction, and, potentially, portrayed a tendency for a slower mood improvement rate with sertraline over the 14 weeks of treatment compared with the other treatment groups. A tentative observation from our depression outcome results … is that there may be relatively little advantage in prescribing an antidepressant alone for depressed patients who are also alcohol dependent.”

The study was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism and by Pfizer Inc., manufacturer of sertraline, which donated the drug and placebo for the study.

source: http://pn.psychiatryonline.org

More Treatment & Detox Articles

Judge considering center for drug, alcohol help program

Court-ordered rehabilitation for drug and alcohol offenders may soon be a locally based option for those facing charges in Lincoln County Justice Court, a choice authorities say would provide them with better options for sentencing and enhance the effectiveness of such treatment. Lincoln County Justice Court Judge Ralph Boone and Post One Probation Officer Roger….

Continue reading

Concern over teenage alcohol abuse

A campaign group has called for more research into the way alcohol can affect teenagers’ health. Alcohol Concern said it was worried that a rise in teenage drinking would lead to more people suffering alcohol-related illnesses at younger ages. The organisation called for further study as it emerged that a 22-year-old man was dying in….

Continue reading

Analysis of alcoholics' brains suggests treatment target

An analysis of brain tissue samples from chronic alcoholics reveals changes that occur at the molecular level in alcohol abuse – and suggests a potential treatment target, according to researchers from Wake Forest University School of Medicine. Reporting in Alcoholism: Clinical and Experimental Research, the scientists said that a protein known as beta-catenin that is….

Continue reading

Drinkers Warned About Risk Of ‘Shakes’

People who consume three alcoholic drinks every day double their risk of getting the “shakes” in later life, researchers have found. Essential tremor, a common neurological disorder, affects an estimated 650,000 people in the UK. Although there are a number of factors which can cause the condition including an overactive thyroid and Parkinson’s disease, alcoholics….

Continue reading

Let’s be honest about alcohol

Like a stereotypical drunk searching in vain for a bottle that’s around here somewhere, it turns out that many Canadians have a hard time understanding exactly what happened to the liquor that they bought. A new study for the University of Victoria’s Centre for Addictions Research, based on a national telephone survey of 13,909 people,….

Continue reading

Where do calls go?

Calls to numbers on a specific treatment center listing will be routed to that treatment center. Calls to any general helpline will be answered or returned by one of the treatment providers listed, each of which is a paid advertiser: ARK Behavioral Health, Recovery Helpline, Alli Addiction Services.

By calling the helpline you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.

I NEED TO TALK TO SOMEONE NOWI NEED TO TALK TO SOMEONE NOW 888-647-0579Response time about 1 min | Response rate 100%
Who Answers?